Heart Valve Market: PAVR Poised for Growth
Article preview reprinted Medtech Insight - January 2009
Much like the early days of coronary stenting, percutaneous aortic valve replacement has captured the imagination of physicians and industry alike.
Heart Valve Market: PAVR Poised for Growth
Article preview reprinted Medtech Insight - January 2009
In the 1990s, catheter-delivered coronary stents revolutionized the treatment of coronary artery disease, ushering in a new era of minimally invasive treatment for patients with heart disease and generating a multibillion-dollar device market in the process. A decade later, transcatheter technologies have the potential to do the same for heart valve replacement and repair procedures.
When Alain Cribier, MD, of University Hospital, Rouen, France, performed the first percutaneous aortic valve replacement procedure in April 2002, many physicians (particularly cardiac surgeons) were skeptical that the technology would ever reach mainstream use due to the complexity and risks involved. However, the milestone achievement left a lasting impression and marked the beginning of a monumental technology development effort with the potential to eventually change the face of the heart valve industry.
Purchase this article online as a PDF and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satisfaction Guaranteed.
Companies mentioned in this article:
Abbott Laboratories Inc.
Advanced Bio Prosthetic Surfaces Ltd.
AorTx Inc.
Bracco SPA
Acist Medical Systems
Bracco Advanced Medical Technologies Inc.
Caritas St. Elizabeth's Medical Center
Columbia University
New York-Presbyterian Hospital
CoreValve Inc.
Direct Flow Medical Inc.
Edwards Lifesciences Corp.
Emory University
Hansen Medical Inc.
Heart Leaflet Technologies Inc.
JenaValve Technology GMBH
Johnson & Johnson
Cordis Corp.
Johnson & Johnson Development Corp.
Medtronic Inc.
Sadra Medical Inc.
Tel Aviv University
START-UP: No publication reviews leading edge companies and technology better than START-UP. Each issue of START-UP profiles the most important new product companies, identifies the hottest technology areas, reviews funds flowing into private companies and investment trends, and reports on university tech transfer licensing. Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics. Subscribe to START-UP.
